Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$47.32

0.76 (1.63%)

14:00
10/02/18
10/02
14:00
10/02/18
14:00

Second day of interest in Novo Nordisk calls

Second day of interest in Novo Nordisk calls. The stock up 70c to $47.26 and 1.9K Nov 48 calls trade for $1.30 when bid-as was $1.1 to 1.35. 3K changed hands and the interest comes after buyers opened 3.7K Oct 47 calls Monday (while closing 2K Oct 49 calls). The interest in NVO calls comes after several months of underperformance in shares, which are down 12% YTD. Earnings due again early-November and outside of the October expiration.

NVO Novo Nordisk
$47.32

0.76 (1.63%)

06/01/18
ROTH
06/01/18
NO CHANGE
Target $400
ROTH
Buy
Roth Capital ups Madrigal price target to $400, examines possible M&A scenarios
Roth Capital analyst Yasmeen Rahimi noted that Madrigal Pharmaceuticals' (MDGL) "impressive" NASH resolution results published yesterday resulted in the stock's value being pushed up to make it the highest among "purely NASH" companies. Among large pharma companies, Rahimi believes those with the strongest metabolic franchises, large R&D teams, and sales forces focused on endocrinologists, gastroenterologists, and hepatologists likely have eyes on NASH assets, listing Merck (MRK), AstraZeneca (AZN), Eli Lilly (LLY) and Novo Nordisk (NVO) as examples. The historical acquisition price for NASH assets ranges from $200M to $1.7B, but Rahimi argues that Madrigal "can set the highest NASH price tag yet," estimating a potential takeout valuation of $5.6B. Rahimi raised her price target on Madrigal shares to $400 from $210 and keeps a Buy rating on the stock.
07/02/18
BERN
07/02/18
UPGRADE
BERN
Outperform
Novo Nordisk upgraded to Outperform from Market Perform at Bernstein
07/19/18
BMOC
07/19/18
NO CHANGE
Target $80
BMOC
Market Perform
Eli Lilly to have a 'good Q2' on beats from launch franchises, says BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Eli Lilly to $80 from $78 ahead of its Q2 earnings, saying the company will have a "good" quarter on "beats from its launch franchises Trulicity, Jardiance, and Basaglar". The analyst also keeps his Market Perform rating, adding that while the the pipeline potential of its Galcanezumab and Tanezumab drugs is promising, he believes investors are underappreciating the headwinds around its diabetes program. He see higher risks of an increased biosimilar erosion for Humalog from Sanofi's (SNY) Admelog, and Trulicity competitive pressure from Novo's (NVO) Ozempic in 2019.
09/19/18
NEED
09/19/18
NO CHANGE
Target $29
NEED
Zealand Pharma price target raised to $29 from $26 at Needham
Needham analyst Alan Carr raised his price target on Zealand Pharma (ZEAL) to $29 and kept his Buy rating after its announced Phase 3 trial results of dasiglucagon in Acute Severe Hypoglycemia. The analyst notes that the trial met its primary median time endpoint for glucose recovery, adding that the rapid response is comparable to the currently marketed Glucagen made by Novo Nordisk (NVO). With phase 3 trial expected to be launched this month, Carr anticipates Zealand's potential commercialization of dasiglucagon to come in 2020 and for peak sales to reach $360M in 2030.

TODAY'S FREE FLY STORIES

HBAN

Huntington Bancshares

$13.66

-0.54 (-3.80%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Huntington Bancshares to make targeted investments in people, technology »

Says local economies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

YMAB

Y-mAbs Therapeutics

$22.00

0.02 (0.09%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Y-mAbs Therapeutics receives recommendation from COMP for OMPD for naxitamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.84

0.02 (0.29%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Upgrade
Snap rating change  »

Snap upgraded to Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

PINC

Premier

$45.14

0.34 (0.76%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Hot Stocks
Adventist Health engages Premier in strategic supply chain initiative »

Adventist Health is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRPX

Therapix Biosciences

$4.39

0.08 (1.86%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Hot Stocks
Therapix Biosciences to be acquired by FDS Pharma in $48M stock deal »

FSD Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$33.52

-0.77 (-2.25%)

09:25
10/23/18
10/23
09:25
10/23/18
09:25
Technical Analysis
Technical Take: Applied Materials drops to new 52-week low, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFF

Griffon

$14.50

0.04 (0.28%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Griffon subsidiary awarded $23.5M contract by NAVAIR »

Telephonics, a wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$54.96

0.07 (0.13%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Verizon says 'confident' wireless business will continue to grow »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

  • 13

    Nov

DSX

Diana Shipping

$3.86

0.05 (1.31%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Diana Shipping to extend time charter contract for Electra with Uniper Global »

Diana Shipping announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$36.24

0.38 (1.06%)

, PF

Pinnacle Foods

$66.61

0.29 (0.44%)

09:23
10/23/18
10/23
09:23
10/23/18
09:23
Hot Stocks
Pinnacle Foods' shareholders approved acquisition by Conagra Brands »

Conagra Brands (CAG) and…

CAG

Conagra Brands

$36.24

0.38 (1.06%)

PF

Pinnacle Foods

$66.61

0.29 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

QCOM

Qualcomm

$66.08

0.72 (1.10%)

, AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

09:23
10/23/18
10/23
09:23
10/23/18
09:23
Hot Stocks
Amazon, Qualcomm to put Alexa assistant in more headphones »

Qualcomm (QCOM) said in a…

QCOM

Qualcomm

$66.08

0.72 (1.10%)

AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

ACB

Aurora Cannabis

$0.00

(0.00%)

, ACBFF

Aurora Cannabis

$0.00

(0.00%)

09:22
10/23/18
10/23
09:22
10/23/18
09:22
Hot Stocks
Aurora Cannabis to commence trading on NYSE today »

Aurora Cannabis will…

ACB

Aurora Cannabis

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$261.03

0.97 (0.37%)

09:21
10/23/18
10/23
09:21
10/23/18
09:21
Recommendations
Tesla analyst commentary  »

Tesla shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

HAL

Halliburton

$36.36

-1.18 (-3.14%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$93.62

-0.28 (-0.30%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Hot Stocks
Medtronic announces FDA approval for Valiant Navion thoracic stent graft system »

Medtronic announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$138.68

-0.32 (-0.23%)

, ITCI

Intra-Cellular

$17.21

-1.02 (-5.60%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Conference/Events
JPMorgan pharma and biotech analysts to hold analyst/industry conference call »

Smid Cap Biotech Analyst…

JNJ

Johnson & Johnson

$138.68

-0.32 (-0.23%)

ITCI

Intra-Cellular

$17.21

-1.02 (-5.60%)

AGN

Allergan

$187.75

-1.87 (-0.99%)

SAGE

Sage Therapeutics

$118.03

-4.29 (-3.51%)

ALKS

Alkermes

$38.86

-1.34 (-3.33%)

ACAD

Acadia

$21.77

-0.46 (-2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 19

    Dec

  • 31

    Jan

EIGR

Eiger BioPharmaceuticals

$10.65

-1.2 (-10.13%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Syndicate
Eiger BioPharmaceuticals 4.2M share Spot Secondary priced at $10.35 »

BTIG acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 23

    Oct

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/23/18
10/23
09:18
10/23/18
09:18
Options
Overnight activity included 825 trades in SPX and 119 trades in VIX »

825 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$31.20

-0.25 (-0.79%)

, F

Ford

$8.41

0.06 (0.72%)

09:17
10/23/18
10/23
09:17
10/23/18
09:17
Hot Stocks
Avis Budget, Ford announce agreement to connect fleet vehicles »

Avis Budget (CAR)…

CAR

Avis Budget

$31.20

-0.25 (-0.79%)

F

Ford

$8.41

0.06 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 13

    Dec

NCR

NCR Corp.

, JTPY

JetPay

$4.97

2.9 (140.10%)

09:15
10/23/18
10/23
09:15
10/23/18
09:15
Recommendations
NCR Corp., JetPay analyst commentary  »

NCR Corp. deal for JetPay…

NCR

NCR Corp.

JTPY

JetPay

$4.97

2.9 (140.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 26

    Nov

  • 29

    Nov

CADE

Cadence Bancorp

$21.65

-0.27 (-1.23%)

09:15
10/23/18
10/23
09:15
10/23/18
09:15
Recommendations
Cadence Bancorp analyst commentary  »

Cadence Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 06

    Dec

09:15
10/23/18
10/23
09:15
10/23/18
09:15
General news
Breaking General news story  »

Minneapolis Federal…

CMP

Compass Minerals

$68.01

-0.08 (-0.12%)

09:14
10/23/18
10/23
09:14
10/23/18
09:14
Earnings
Compass Minerals sees FY18 EPS $2.20-$2.50, consensus $2.83 »

Compass Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

FITB

Fifth Third

$25.38

-0.95 (-3.61%)

09:14
10/23/18
10/23
09:14
10/23/18
09:14
Hot Stocks
Breaking Hot Stocks news story on Fifth Third »

Fifth Third says at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

HPQ

HP Inc.

$24.11

0.26 (1.09%)

09:13
10/23/18
10/23
09:13
10/23/18
09:13
Hot Stocks
HP Inc., NTU Singapore and NRF collaborate on corporate innovation lab »

Nanyang Technological…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.